Frank Hazevoets

Chief Executive Officer bij DMS IMAGING

57 jaar

Health Technology

Consumer Non-Durables

Consumer Services

Actieve functies van Frank Hazevoets

Bedrijven	Functie	Begin	Einde
DMS IMAGING	Director/Board Member	02-05-2019	-
	Chief Executive Officer	13-10-2020	-
	Director of Finance/CFO	01-01-2020	-
	Investor Relations Contact	01-04-2019	-

Bedrijven	Functie	Begin	Einde
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.	Director of Finance/CFO	01-05-2014	05-10-2018
TIGENIX NV	Director of Finance/CFO	01-01-2006	01-01-2012
TIGENIX NV	Corporate Secretary	01-01-2006	01-01-2012
InBev SA	Corporate Officer/Principal	01-01-2001	01-01-2006
Smeets Securities BV	Corporate Officer/Principal	-	-
Puilaetco	Corporate Officer/Principal	-	-

Université Catholique de Louvain

Graduate Degree

Internationaal

België	7
	2

Operationeel

Director of Finance/CFO	3
Corporate Officer/Principal	3
Corporate Secretary	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
DMS IMAGING	Health Technology

Bedrijven in privébezit	5
InBev SA	Consumer Non-Durables
TiGenix NV TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium.	Health Technology
Smeets Securities BV
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.	Health Technology
Puilaetco	Finance